Prevalence, Risk Factors, and Treatment Outcomes of Isoniazid- and Rifampicin-Mono-Resistant Pulmonary Tuberculosis in Lima, Peru
General Info
Time period covered
January, 2010 - December, 2011
Data type
Scientific literature
Keywords
Citation
Journal
PLoS One
Pages
e0152933
Publication year
2016
Suggested citation
Villegas L, Otero L, Sterling TR, Huaman MA, Van der Stuyft P, Gotuzzo E, Seas C. Prevalence, Risk Factors, and Treatment Outcomes of Isoniazid- and Rifampicin-Mono-Resistant Pulmonary Tuberculosis in Lima, Peru. PLoS One. 2016; 11(4): e0152933.